Will Oklo Stock Double?
Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…
Sell
29
MRSN Quote, Financials, Valuation and Earnings
Last price:
$0.34
Seasonality move
:
-25.5%
Day range:
$0.34 - $0.39
52-week range:
$0.26 - $2.83
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.25x
P/B ratio:
57.95x
Volume:
4.5M
Avg. volume:
2.9M
1-year change:
-83.06%
Market cap:
$42.9M
Revenue:
$40.5M
EPS (TTM):
-$0.59
MRSN Analysts' Consensus Rating
The 9 analysts providing 12-month price projections for Mersana Therapeutics shares anticipate an average target of $4.29, ranging from a low estimate of $1.00 to a high estimate of $10.00. This average target implies a growth of 1146.21% compared to the current stock price of $0.34.
Consensus Price Target
$4.29
Highest Price Target
$10.00
Lowest Price Target
$1.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 8 | 8 | 8 |
| Hold | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
MRSN Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why a $5 Stock Is Suddenly a Cash Machine
If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…
Is Roku Stock Undervalued Now?
At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…
Stock Ideas
Buy
69
Is NVDA Stock a Buy?
Market Cap: $4T
P/E Ratio: 56x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 43x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
58
INKT alert for Jul 14
MiNK Therapeutics [INKT] is down 36.03% over the past day.
Buy
51
NEGG alert for Jul 14
Newegg Commerce [NEGG] is down 26.42% over the past day.
Buy
68
ATRO alert for Jul 14
Astronics [ATRO] is down 1.02% over the past day.
